High Tower Advisors, LLC Adaptimmune Therapeutics PLC Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$1.33 - $2.28 $20,149 - $34,542
-15,150 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$1.73 - $4.06 $1,989 - $4,669
1,150 Added 8.21%
15,150 $31,000
Q3 2021

Nov 12, 2021
SELL
$3.44 - $6.37 $3,440 - $6,370
-1,000 Reduced 6.67%
14,000 $72,000
Q2 2021

Aug 06, 2021
BUY
$3.86 - $5.78 $57,900 - $86,700
15,000 New
15,000 $64,000

Others Institutions Holding ADAP

# of Institutions
83
Shares Held
150M
Call Options Held
60.8K
Put Options Held
5.8K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $96.4M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email